1. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
   Qi Jin et al, 2023, Frontiers in Pharmacology CrossRef
2. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
   You Huang et al, 2024, Frontiers in Pharmacology CrossRef
3. Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs
   Feifei Qiu et al, 2021, Frontiers in Immunology CrossRef
4. The protective effect of teprenone in TNBS-induced ulcerative colitis rats by modulating the gut microbiota and reducing inflammatory response
   Jianfeng Yao et al, 2024, Immunopharmacology and Immunotoxicology CrossRef
5. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial–mesenchymal transition
   Manxiu Huai et al, 2021, International Immunopharmacology CrossRef
6. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease
   Mohammad Aadil Bhat et al, 2024, Current Reviews in Clinical and Experimental Pharmacology CrossRef
7. RETRACTED ARTICLE: A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis
   Farnaz Farsi et al, 2021, European Journal of Nutrition CrossRef
8. Dietary Aflatoxin B1 attenuates immune function of immune organs in grass carp (Ctenopharyngodon idella) by modulating NF-κB and the TOR signaling pathway
   Xiang-Ning He et al, 2022, Frontiers in Immunology CrossRef